Quectel Expands LTE Portfolio with Direct-to-Cell (D2C) Capabilities Enabling 100 Percent Global Reach for IoT Developers
11.9.2025 13:00:00 CEST | Business Wire | Press Release
Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announced that several of its LTE modules are now available with Direct-to-Cell (D2C) functionality, enabling devices to seamlessly connect to satellite networks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250911087809/en/
Quectel expands LTE portfolio with Direct-to-Cell (D2C) capabilities enabling 100 percent global reach for IoT developers
By integrating D2C technology at the module level, Quectel enables devices to extend beyond the limits of ground-based cellular networks by seamlessly leveraging satellite networks. This ensures customers can stay connected virtually anywhere in the world, eliminating the connectivity gaps often encountered in rural or remote areas. Ultimately, this will help to simplify IoT deployments, reducing time-to-market and lowering costs by eliminating the need for specialized satellite hardware. Device manufacturers and developers can now build scalable IoT solutions with global reach, ensuring reliable connectivity virtually anywhere.
“Direct-to-Cell represents a major step forward in connecting the unconnected,” said Delbert Sun, Vice General Manager, Quectel Wireless Solutions. “By integrating D2C technology into our LTE modules, we are enabling customers to deploy IoT solutions that remain online everywhere, from cities to the most remote environments, without additional hardware complexity.”
Quectel’s enhanced D2C portfolio includes a wide range of LTE modules to address diverse global markets and operator requirements:
With leading mobile network operators already preparing to support this technology at scale and aligned to enable D2C services, Quectel’s modules are designed to integrate seamlessly into evolving satellite ecosystems. The development of the Quectel product range that devices using Quectel’s LTE modules with D2C technology will be ready to connect as operators activate their D2C networks worldwide.
These D2C-enabled LTE modules are designed to support a wide range of applications across industries, including residential and commercial fixed subscribers who require reliable broadband connectivity, maritime communication subscribers needing stable connections for vessels and offshore platforms, RV mobile subscribers seeking always-on internet access for recreational vehicles and mobile lifestyles, and aviation communication subscribers who depend on in-flight connectivity and aviation IoT applications.
With Direct-to-Cell support, Quectel is helping unlock the next generation of IoT connectivity by bridging terrestrial and satellite networks. By enabling devices to communicate directly with satellites using existing cellular protocols, Quectel’s D2C modules deliver global coverage, greater resiliency, and simplified device management for mission-critical and consumer applications alike.
Quectel also offers a range of high-performance antennas engineered to support Direct-to-Cell connectivity alongside its LTE modules. By combining Quectel’s D2C-enabled modules with its antennas, customers gain optimized compatibility and performance, ensuring reliable satellite and terrestrial communication in even the most challenging environments. Purchasing both modules and antennas directly from Quectel removes the need for compatibility testing with third-party solutions, delivering a streamlined, cost-effective, and future-ready path to Direct-to-Cell connectivity.
About Quectel
Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are an end-to-end global IoT solutions provider backed by outstanding support and services.
With a global team of over 5,800 professionals, we lead the way in delivering end-to-end IoT solutions, spanning cellular, GNSS, satellite, Wi-Fi and Bluetooth modules, high-performance antennas, value-added services and full turnkey offerings including ODM services and system integration.
With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.
For more information, please visit: www.quectel.com or LinkedIn
View source version on businesswire.com: https://www.businesswire.com/news/home/20250911087809/en/
Contacts
Media contact: media@quectel.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom